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The aging process is characterized by the chronic inflammatory status called
“inflammaging”, which shares major molecular and cellular features with the
metabolism-induced inflammation called “metaflammation.” Metaflammation is mainly
driven by overnutrition and nutrient excess, but other contributing factors are metabolic
modifications related to the specific body composition (BC) changes occurring with
age. The aging process is indeed characterized by an increase in body total fat mass
and a concomitant decrease in lean mass and bone density, that are independent
from general and physiological fluctuations in weight and body mass index (BMI). Body
adiposity is also re-distributed with age, resulting in a general increase in trunk fat
(mainly abdominal fat) and a reduction in appendicular fat (mainly subcutaneous fat).
Moreover, the accumulation of fat infiltration in organs such as liver and muscles also
increases in elderly, while subcutaneous fat mass tends to decrease. These specific
variations in BC are considered risk factors for the major age-related diseases, such
as cardiovascular diseases, type 2 diabetes, sarcopenia and osteoporosis, and can
predispose to disabilities. Thus, the maintenance of a balance rate of fat, muscle
and bone is crucial to preserve metabolic homeostasis and a health status, positively
contributing to a successful aging. For this reason, a detailed assessment of BC in elderly
is critical and could be an additional preventive personalized strategy for age-related
diseases. Despite BMI and other clinical measures, such as waist circumference
measurement, waist-hip ratio, underwater weighing and bioelectrical impedance, are
widely used as a surrogate measure for body adiposity, they barely reflect the distribution
of body fat. Because of the great advantages offered by imaging tools in research and
clinics, the attention of clinicians is now moving to powerful imaging techniques such as
computed tomography, magnetic resonance imaging, dual-energy X-ray absorptiometry
and ultrasound to obtain a more accurate estimation of BC. The aim of this review is
to present the state of the art of the imaging techniques that are currently available to
measure BC and that can be applied to the study of BC changes in the elderly, outlining
advantages and disadvantages of each technique.
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INTRODUCTION
The rapid increase of elderly population represents a
global health problem (1) together with the concurred
increased incidence of age-related diseases, including type
2 diabetes mellitus (T2DM), obesity, metabolic syndrome
and cardiovascular diseases (CVD). The new field known as
“geroscience” recognized that these chronic pathologies and
aging itself share seven interconnected common mechanistic
pillars such as epigenetics, adaptation to stress, stem cells and
regeneration, proteostasis, macromolecular damage, metabolism
and inflammation (2). To date, gerontologists propose to focus
on these basic agingmechanisms to successfully counteract all the
major age-related diseases, and to slow down the aging process
(3). In particular, the chronic low grade inflammatory status
occurring during aging, called “inflammaging,” (4, 5) is tightly
linked to metabolism, because any impairment of metabolic
pathways can fuel inflammation. This metabolism-induced
inflammation has been recently named “metaflammation” (6).
Modern research aimed at finding potential sources of low-grade
inflammation is now focusing on the major molecular and
cellular mechanisms such as cellular senescence, mitochondrial
dysfunction, activation of the inflammasome (7) and changes
in gut microbiota composition, which mostly overlap with
metaflammation and inflammaging (8). Several studies showed
that metaflammation may trigger obesity-induced insulin
resistance, suggesting a causative role in T2DM itself (9) and in
diabetes-induced complications (10). Murine models of diabetes
and obesity showed that an overexpression of pro-inflammatory
molecules in fat tissue occur, which in turn increases insulin
sensitivity (11). Several studies also revealed that the adipose
tissue is a main source of inflammatory molecules, such as
IL-6 and MCP1 (12, 13). Metaflammation is mainly driven by
overnutrition and nutrient excess (3, 14), which are present in
metabolic diseases, but body composition changes occurring with
age can also contribute. Indeed, the aging process is characterized
by an increase in body total fat mass and a concomitant decrease
in lean mass and bone density, that are independent from general
and physiological fluctuations in weight and body mass index
(BMI) (15). Moreover, the accumulation of muscle fat, visceral
fat and liver fat, in form of lipid droplets (LD), also shows an
age-dependent increase, while an opposite tendency is observed
for subcutaneous fat mass (16). However, it should be taken
into account that when the decrease of subcutaneous peripheral
fat becomes excessive, it is associated with a pro-inflammatory
status, and a reduction of LDs is associated with lipotoxicity
(17) leading to CVD, an increased risk of insulin resistance
and T2DM. Thus, in order to preserve a metabolic homeostasis
and a health status positively contributing to longevity, it
is desirable to maintain a balanced rate of fat content and
distribution (18). For this reason, a detailed assessment of body
composition (BC) in elderly is critical and could be an additional
preventive personalized strategy for age-related diseases. The
most commonly used method to investigate BC employs a
five-level model, which make it possible to classify the human
body according to five levels of increasing complexity: I, atomic;
II, molecular; III, cellular; IV, tissue-organ; V, whole body. To
date, whole-body, organ-tissue, and molecular levels are the
most studied in human BC assessment. BMI measurement is
widely used as a surrogate measure for body fatness, due to
the simplicity of anthropometric methods and the widespread
availability of techniques to assess it, however it does not reflect
the precise distribution of body fat. A hierarchical cluster analysis
based on BMI together with BC parameters revealed that clusters
with very similar BMI have a different amount of fat, lean and
bone masses (19). Numerous clinical methods and techniques
such as waist circumference measurement, waist-hip ratio,
underwater weighing and bioelectrical impedance analyses are
also available. However, the attention of clinicians has recently
focused to several imaging techniques to study BC, because of
the great advantages offered by imaging tools in the research
and clinical aspects of this field (20, 21). The imaging methods
used to analyze BC aim to divide body mass into its components
based on their different physical properties. Depending on the
information sought, several methods can be used to measure BC,
such as computed tomography, magnetic resonance imaging,
dual-energy X-ray absorptiometry and ultrasound, each showing
specific advantages and limitations. In selecting the diagnostic
imaging method, one should consider the accuracy and type of
the information obtained, the safety of assessment (e.g. in terms
of radiation exposure), the time required and costs (equipment
and personnel) (Tables 1, 2). Nowadays, Dual-energy X-ray
Absorptiometry (DXA) represents a reference method for the
assessment of human BC in the research field (22, 23), due to
its fast acquisition time, low radiation exposure and relatively
low cost when compared to other available techniques (24–27).
Within the framework of the European NU-AGE project
(conducted from 2011 to 2016) a DXA scan has been carried
out in a large number (N = 1,121) of sex-balanced, free-living,
apparently healthy older adults aged 65–79 years enrolled in 5
European countries (Italy, France, United Kingdom, Netherlands
and Poland) (28) for the first time. The results showed that BC
characteristics are different in elderly women and men across
Europe (19) and that a better adipose-related inflammatory
profile is associated to a more favorable BC in terms of fat and
lean mass markers (29). In this review, we summarize the present
knowledge of available imaging methods to measure BC, with a
focus on the measurement of BC changes occurring with age and
we discuss pros and cons of each technique.
DUAL-ENERGY X-RAY ABSORPTIOMETRY
(DXA)
DXA was originally developed to evaluate bone mineral density,
but it has gained popularity as a method to assess whole-
body and regional soft-tissue composition. DXA divides the
body into three components; bone mineral content (BMC),
lean mass (LM) and fat mass (FM). Since the method assesses
three body-composition components at a molecular level, it is
widely considered as the gold standard for BC assessment in
clinical practice.
This technique is based on the physical principle that X-rays
of different energies are differentially attenuated when passing
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TABLE 1 | Overview of body composition methods for assessing adiposity and regional fat depots in older adults.
Body fat compartment
Method Frequently used
measures
Visceral
fat
Inter-/
intramuscolar fat
Whole body
fat
Low cost Availability Radiation
exposure
Precision Accuracy
Anthropometry Body Mass Index + + ++ +++ +++ +++ + ++
Skinfold thickness + + ++ +++ +++ +++ + +
Waist circumference ++ + ++ +++ +++ +++ + +
Arm circumference + + + +++ +++ +++ + ++
Predicted fat mass + + ++ +++ +++ +++ + +
Bioelectrical
impedance
Predicted fat mass + + ++ +++ +++ +++ + +++
Ultrasound Mid-tight image (+)++ ++ + +++ +++ +++ ++ +++
Dual energy
X-ray
absorptiometry
Whole body scan ++ + +++ ++ ++ ++ +++ +++
Computed
tomography
Abdominal image +++ ++ + + + + +++ ++
Mid-tight image + +++ + + + + +++ +++
Magnetic
resonance
imaging
Abdominal image +++ ++ + + + +++ +++ ++
Mid-tight image + +++ + + + +++ +++ +++
Total body multi
image
+++ +++ +++ + + +++ +++ ++
+++ indicates a very positive feature of the method, while + indicates a less positive feature.
TABLE 2 | Overview of body composition methods for assessing whole body and regional skeletal muscle in older adults.
Skeletal muscle compartment
Method Frequently used
measures
Regional muscle Whole body muscle Low cost Availability Radiation
exposure
Precision Accuracy
Anthropometry Arm circumference ++ + +++ +++ +++ + +
Calf circumference ++ + +++ +++ +++ + +
Predicted ASMM + ++ +++ +++ +++ + +
Bioelectrical
impedance
Predicted FFM mass + + +++ +++ +++ + +++
Predicted ASMM ++ ++ +++ +++ +++ + +++
Ultrasound Mid-tight image ++ + +++ +++ +++ ++ +++
Dual energy X-ray
absorptiometry
Whole body scan +++ ++ ++ ++ ++ (+)++ +++
Computed tomography Mid-tight image +++ + + + + +++ +++
Magnetic resonance
imaging
Mid-tight image +++ + + + +++ +++ +++
Total body multi
image
+++ +++ + + +++ +++ ++
ASMM, Appendicular Skeletal Muscle Mass; FFM, Fat-Free Mass.
+++ indicates a very positive feature of the method, while + indicates a less positive feature.
through the various tissues of human body. By radiating the body
in anterior-posterior direction using two different energies, and
assuming a two-compartment model in each measurement point
(pixel), the image can be reconstructed; the two-compartment
model assumes that pixels not containing bone depend on LM
and FM ratio, and that pixels containing bone depend on BMC
and soft tissue ratio with a subsequent interpolation of LM and
FM ratio based on neighboring pixels not containing bone.
DXA allows total-body and standard regional body
composition measures, including trunk, arms, legs, android
and gynoid regions, and ideally, can estimate every human body
part of interest (Figure 1).
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In addition, it is now possible to estimate with DXA the
amount of visceral adipose tissue (VAT) and subcutaneous
adipose tissue (SAT) in the android region that represent, a
harmful factor and a presumable protective factor, respectively,
in cardio-metabolic status of patient.
The DXA approach represents a good candidate to be a gold
standard technique to measure longitudinal changes in BC in
multiple pathologic or paraphysiologic conditions because of its
high accuracy and precision, large availability, and low-cost.
DXA is a non-invasive, quick and safe method for BC
assessment, and the radiation exposure is considered small
and safe for repeated measures (a whole-body scan takes only
6–10min and the radiation exposure is equivalent to a day
spent sunbathing).
Currently available DXA systems for scanning whole-body
tissue composition are capable to analyze a wide range of weights
and sizes, including severe obese subjects (>200 kg with relatively
wide scanning space>65 cm).
Amarked impaired hydration status may affect DXA accuracy
because of the programmed assumption of a constant and
uniform LM hydration (25).
Reference values of BC assessed by DXA on adults over 60
years old are available from the National Health and Nutrition
Examination Survey 1999–2004 and from other studies on local
population (30).
ULTRASOUND (US)
Ultrasound is another technique that has been used for a long
time to assess FM. US, based on echo reflections, offers a
two-dimensional gray-scale image, between black (no echoes)
and white (strong reflections), and shows skin-subcutaneous fat
borders, fat-muscle, and muscle-bone interfaces (31). Although
US procedures are considered accurate, reproducible, and fast
for the analysis of abdominal adiposity by allowing a local, easy
and close-at-hand evaluation of subcutaneous and visceral fat
compartments (32), there are different opinions about its validity.
Borkan et al. suggested that with respect of ultrasound, skinfolds
were a better measure of subcutaneous fat (33), while Fanelli
and Kuczmarski proposed that US was identical to skinfolds
when determining body fat (34). US intra-abdominal thickness
measurement was introduced by Armellini and colleagues to
demonstrate that US was the most powerful identifier of visceral
adipose tissue area into intra-abdominal thickness (35, 36).
It is easy to understand how the absence of a straight
standardized protocol leads to a decrease in accuracy
and reliability of US measurements of BC, mainly for
visceral adiposity. In a recent study was demonstrated that
reproducibility and repeatability, especially for visceral fat, were
proved more stable in fasting state and expiration (37).
COMPUTED TOMOGRAPHY (CT) AND
MAGNETIC RESONANCE IMAGING (MRI)
CT andMRI are cross-sectional imagingmodalities providing 2D
or 3Dmaps of pixels allowing for the in vivomeasurement of lean
mass and total adipose tissue and its subdepots (subcutaneous,
intermuscular, and visceral).
CT presents great practical significance due to its routinely
use for diagnosis and follow-up in various diseases and allows an
accurate quantification of whole-body composition (Figure 2).
Being a volumetric technique, CT allows to measure body
components at tissue-level using pre-established Hounsfield
Units (HU) to recognize different tissue density (soft tissue: 30–
50HU; fluid-sovrafluid: 0–30HU; adipose tissue:−100HU; bone
and calcification: 100–1000 HU).
CT imaging at L3 level provides total, visceral or subcutaneous
adipose fat area, visceral adipose volume, total psoas area,
and skeletal muscle index (SMI) (38). Moreover, according to
ethnicity- and sex-specific data, CT has been used to derive
a predictive cardio-metabolic risk (CMR) equation (39). This
type of evidence endorsed other specific research, analyzing
pericardial fat, intrathoracic fat and epicardial fat, showing the
potential contribution in CMR stratification (40). Also, because
CT images targeted on the III lumbar vertebra are similar to
those on chest, they could be tentatively performed solely. As
CT usage has now increased in clinical practice, the radiation
exposure should be taken in mind, since it represents a risk factor
for oncologic disease development.
Differently from CT that is calibrated against the Hounsfield
scale, signal intensities inMRI are often non-quantitative because
image intensity values do not reflect physical properties of
the imaged body. MRI allows to measure body fat-free mass
such as skeletal muscle mass at arms, legs and trunk level,
specific organ masses, and provides also an estimate of bone
marrow adipose tissue (41). From a technical point of view
body composition measurement with MRI is based on the
different magnetic properties of hydrogen nuclei contained in
water and fat. Several MRI sequences have been developed
to measure body fat, using variations in radiofrequency pulse
to differentiate between adipose tissue and fat-free mass (27).
A variety of pulse sequences are thus available to generate
contrast between fat and non-adipose tissue (42). Adipose
tissue is characterized by a short T1 and a long T2 relaxation
time; in T1-weighted spin-echo sequence, fat appears as a
high signal (white) because of a high concentration of relative
immobile protons, thus differentiating it from muscles, fluids,
bone and internal organs, which appear as gray signals (43).
The time of acquisition for such sequences is relatively long
and implies some issues, such as respiratory/motion artifacts.
Variations of this sequence have been developed in order to
reduce the acquisition time. Nowadays, a whole-body MRI scan
of an individual can be obtained in about 5min, allowing
for the detailed evaluation of total and regional fat depots.
Whole-body scanning is the most accurate and reproducible
protocol to obtain an accurate quantitative map of body fat
distribution and content, but it has been mainly limited to
research studies due to the high scan costs and the need
of time-consuming image analysis (44). In fact, the amount
of data generated by whole-body MRI requires a complex
analysis, generally not manually feasible, except for very small
studies. In the last years, this has led to the development of
semiautomated or automated methods for MRI-based body
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FIGURE 1 | Dual-energy X-Ray absorptiometry (DXA) examination of body composition. In the center of the picture (E) is represented the skeletal map of whole body
scan by DXA highlighting the standard ROIs specifics for body composition assessment (head—H, trunk—T, upper limbs—U, lower limbs—L), with the two regions at
“high metabolic significance” representing by gynoid (G) and android (A) regions. On the side are depicted the soft tissue maps of whole body DXA scan (from fat
mass—yellow—to bone mass—blue); in particular on the left are visualized old (A) and young (C) males (respectively upper and lower), while in the right old (B) and
young (D) females (respectively upper and lower), highlighting the increase of fat mass in aging. Images are kindly provided by IRCCS Rizzoli Orthopedic Institute, Unit
of Diagnostic and Interventional Radiology (2019).
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FIGURE 2 | CT images of the android region. CT image slices of the android region showing changes in adiposity distribution (visceral fat—arrowheads; subcutaneous
fat—arrows) depending on age and sex: (A) young male, (B) old male, (C) young female, (D) old female. With advancing age, there is a redistribution of fat mass
compartment with increase of visceral compartment for both sexes (in particular for males); it is also noteworthy that the subcutaneous compartment is prevalent in
females, both in young and old age. Images are kindly provided by IRCCS Rizzoli Orthopedic Institute, Unit of Diagnostic and Interventional Radiology (2019).
composition analysis. Furthermore, single-slice and region-
specific multi-slice protocols were developed to make data
analysis easier and faster (Figure 3) (43, 45). An alternative to
whole-body imaging is the acquisition of the solely abdominal
region, which allows to measure fat depots frequently associated
with CMR factors, like visceral adiposity (46). Multi-slice
protocols have become the preferredmethod for large population
studies, while single-slice protocols have been mainly used in
small cohort studies, even if a number of protocols differ in
the landmarks to be used for acquisition; the level of L4–L5
has been the most commonly reported anatomical landmark
for single-slice imaging, while a level close to L2–L3 has been
considered by several authors as the preferable site to evaluate
visceral adipose tissue depot (41, 43). A poor prediction of
visceral and subcutaneous tissue changes was reported in a
longitudinal study with single-slice MRI evaluation at L4–L5
level (47).
There is an increasing interest in using MRI to evaluate
age-related muscle changes to understand the contribution
of poor muscle quality and fat infiltration in sarcopenia.
Recently, Yang et al. demonstrated that a single slice cross-
sectional area at mid-femur can be used in clinical practice
for a fast and non-invasive diagnosis of sarcopenia in old
adults (48). Compared to other imaging techniques, a key
advantage of MRI is the ability to detect changes in the
muscle structure occurring during the aging process or
during disease progression, making this technique a powerful
tool in longitudinal studies. Quantitative magnetic resonance
imaging (QMRI) can be achieved by proton nuclear magnetic
spectroscopy or magnetic resonance spectroscopy (MRS),
which allows the accurate measurement of intramyocellular
lipid and extramyocellular lipid in muscle fibers. MRS can
precisely discriminate adipose and lean tissue by enhancing
contrast, offering the possibility to estimate the accumulation
of tryglicerides in non-adipose tissue (ectopic lipid). Diffuse
fat infiltration in organs and lean tissue can be also estimated
using “quantitative fat-water imaging,” which is based on Dixon
imaging, a gradient recalled echo imaging method which uses
the chemical shift between proton resonance frequencies in
water and in fat (44). MRI shows the best contrast between
fat and muscle tissue, allowing for an accurate evaluation
of muscle quality. It has been shown to possess a higher
sensitivity compared to CT in detecting early fatty replacement
in muscles (49). Differently from DXA, QMRI has the great
advantage to be independent of fat-free mass hydration level,
showing great accuracy and low-minimal changes detectable
in longitudinal studies. However, underestimation of fat mass
and overestimation of fat-free mass by QMRI compared with
a 4-compartments model has been reported (50). In old adults
infiltration of adipose tissue is recognized as a predictor of
poor muscle and mobility functions. MRI was used to study
intramuscular adipose tissue in frail and non-frail individuals,
showing that more muscle fat infiltration was detectable in
older frail subjects (18.0 vs. 11.7%) (51). In women over 50
years old, MRI-measured muscle fat infiltration was reported
to be positively associated with increased fracture risk (52),
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FIGURE 3 | MR T1-weighted image slices of the gynoid region showing age-related muscle changes in both sexes (poor muscle quality and fat infiltration—arrows). In
addition larger subcutaneous adipose tissue are observed in the gynoid region of an old female (D) compared to a young female (C); on the contrary the
representation of subcutaneous compartment in the same region is the same both for a young male (A) and an old male (B). Images are kindly provided by IRCCS
Rizzoli Orthopedic Institute, Unit of Diagnostic and Interventional Radiology (2019).
while lower extremity muscle fat infiltration was shown to
be negatively associated with performance based measures of
physical function (53).
Currently, MRI represents the most advanced and accurate
technique for the study of body composition, by allowing the
measurement and quality assessment of muscle volume and
cross-sectional analysis. Its ability to detect changes in the
muscle structure occurring with aging makes this technique
extremely fascinating to understand age-related progressive loss
of muscle strength and quality. MRI, together with CT, represents
the gold-standard technique in exploring muscle mass and
quality for research purpose, however the limited access to
the equipment, the complexity of data analysis and high cost,
limit the use of MRI routinely in clinical practice (54). A
strong methodological weakness is represented by the lack of
a standardized evaluation protocol in image analysis, limiting
comparison between studies (55).
CHANGES IN BODY COMPOSITION WITH
AGE
Overall Adiposity
From young age to about 75 years old, body weight and
consequently BMI usually increases. This trend is followed
by a decline with an intermediate period of stability (56).
Due to physiologic height loss with aging, the BMI in
elderly may be overestimated in weight-stable persons and
this condition is particularly true in women >85 years old
(57). In elderly, recurrent weight changes events are usual and
the individual evolutions of body weight and BMI are very
miscellaneous (58, 59).
In a healthy Italian population, an increase of FM and a
decrease of LMwere detected up to 70 years old, although women
were less affected by this phenomenon. As the matter of fact
FM in women increased up to the first four decades of life and
remained steady afterwards, differently from the development
of FM in men (remarkable increase, especially after 60 years
old) (22).
Consequently, the percentage of body fat in both sexes
increases up to∼70 years old, but these percentage modifications
appear less evident later, because of a trend to a reduction in fat
mass after 80 years old (60). In weight stable old adults, the loss
of skeletal muscle mass contributes to an increase in body fat
percentage (61, 62).
The complex and partially unknown endocrine role of
adipose tissue on muscle metabolism emphasizes the existence
of an adipo-muscular axis that can influence metabolic changes
between physiologic and pathologic states, including obesity and
inflammation, but also in para-physiologic conditions such as
aging. As examples, an accelerated loss of LM has been associated
with greater body fatness in old age and a significantly greater
quantity of LM is lost during weight loss than is gained during
weight increase, specifically in old men (63, 64).
Body Fat Distribution
A general increase in trunk fat (largely visceral fat) and a decrease
in appendicular fat (largely subcutaneous fat) have been observed
with age. The reduction in subcutaneous adipose tissues has
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also been confirmed using whole-body MRI as well as CT data
of the mid-thigh or US measurements at abdominal level. The
increase in abdominal adiposity has been estimated through
anthropometric methods such as waist circumference, but a
direct measurement can be obtained only by imaging techniques
such as CT and MRI (expensive but accurate) as well as US and
DXA (available but less accurate).
In a recent study evaluating adipositymarkers of visceral fat by
US, no differences were found betweenmales and females in their
30 to 50 s, while a significant difference emerged for those in their
60 to 70 s; the visceral fat content increases noticeably during
aging in males, while in females major changes were significantly
observed in the preperitoneal circumference (65).
Considering DXA imaging analysis, a significant
redistribution of both central and visceral FM was shown
to happen for men during their lifetime, but not for women. In a
healthy sample, android and visceral fat progressively increased
in elderly males, while females, in old decades, seem to go toward
a less pronounced android or visceral redistribution of fat. While
in healthy females the central FM distribution maintains a stable
android/gynoid ratio, Bazzocchi et al. showed that in males a
linear progression to an abdominal redistribution of FM could be
observed over time. In particular, SAT depots were significantly
higher in females, becoming nearly overlapping in males and
females from 50 to 70 years old (22).
Apart from the redistribution of body fat, another feature
of old age-related BC changes are the accumulation of fat
infiltration into non-fat tissues. The alterations in ectopic fat
have been mostly studied in aging muscles, especially with
the support of whole-body MRI scans. Several evidences in
literature suggests that the amount of inter-muscular adipose
tissue increases rapidly with aging: about +10% and +6% per
year in old men and women, respectively. In particular, the
increase in inter-muscular adipose tissue is most visible in those
who underwent an increase in total body weight, but it also
accumulates in people who experience weight loss (66–68).
Skeletal Muscle Mass
In 1997, the age-related loss of muscle mass was termed
sarcopenia, from the Greek words sarx (meaning flesh) and penia
(meaning loss). Forbes and Reina were among the first to report
prospective data that showed an age-related decrease in lean body
mass (about−0.41 kg per year in adults).
However, it is globally accepted today that the concepts of low
lean mass and decreased muscle function should necessarily be
both incorporated into a current definition of sarcopenia.
According to this tendency, several working groups
worldwide have new consensus definitions of sarcopenia
published in recent years, even if a unique consensus with regard
to the specific cut-off point or the most appropriate technique
for assessment of low skeletal muscle mass in old adults has not
been identified yet (23, 69–71).
In some studies, the deterioration in skeletal muscle mass in
elderly have been measured by using 24-h urinary creatinine
excretion and CT cross-sectional area, providing an accurate
assessment of the skeletal muscle mass loss because other lean
tissues, in particular bone and visceral organs, are excluded from
muscle evaluation. From these findings, the relative yearly decline
in the skeletal muscle mass was evaluated to be between −0.64
and −1.29% per year for old men, and between −0.53 and
−0.84% per year for old women (63, 66, 67, 72–74). Both the
increase in body fat and the loss of muscle mass with age make
old adults at a higher risk of developing sarcopenic obesity, a
condition characterized by excess of body adiposity associated
with a reduced muscle mass and/or strength (75, 76).
More recent studies using DXA showed a general decrease of
LM at upper and lower limbs with age in both sexes. Considering
FM/LM distribution at the appendicular body, the decrease of
LM was associated to an increase of FM. In particular, LM
impoverishment was reported after 40 years in men (remarkably
after 50 years old), and later, in the 50 years old, in women.
Moreover, women seemed to maintain a more favorable arm
masses ratio during aging. In this study, anthropometry was
reported to be scarcely representative of LM of arms in both
genders, independently of age, therefore the authors suggested
that a correct assessment of BC at limbs should be achieved by
imaging such as DXA (22, 77).
ASSOCIATIONS OF FAT MASS WITH
MOBILITY, DISABILITY, AND MORTALITY
In the elderly, obesity determined by a high BMI has been
shown to be tightly associated with a decline in functional
performances, possibly leading to disability. For example, a
prospective study from Koster et al. involving almost 3,000
participants between 70 and 79 years old showed that a BMI
above or equal 30 kg/m2 was associated with a 60% increased risk
of mobility limitations, which was reported to be independent of
the participants lifestyle habits. This finding is consistent with
the idea that obesity could be an important factor affecting the
functional status of individuals rather than a mere indicator of
physical inactivity (78).
It is not clear if an increased risk of functional limitations
in the elderly is also associated with overweight, i.e., a BMI
comprised between 25.0 and 29.9 kg/m2. A study involving 406
participants aged 70–89 years showed that the risk of developing
major mobility limitations was reduced in overweight individuals
compared to normal weight or obese subjects. However, several
studies indicated that a high abundance of body adiposity in the
elderly may lead to an increased risk of mobility limitations and
disability (79–85).
Adiposity is not the only determinant of functional status in
old age; individual lifetime histories of being overweight or obese
is also to be considered when considering the risk of disability. It
has been reported that in older men and women who have been
overweight or obese since age 25, the risk of developing mobility
limitations was almost 3 times higher compared to individuals
which maintained a normal weight throughout their lifetime.
Conversely, individuals who became overweight or obese only
in old age showed a risk 1.7 times higher. Thus, a longer history
of high body fatness appears to augment the risk of functional
failure in old age. Weight gain is another significant determinant
of functional performances in advancing age, as suggested by
Frontiers in Endocrinology | www.frontiersin.org 8 January 2020 | Volume 10 | Article 861
Ponti et al. Imaging, Aging, and Body Composition
several prospective studies. For example, in a cohort of almost
3,000 Italian individuals over 65 years old, a weight gain of more
than 5% after their 50s was correlated with an augmented risk of
limitations in activities of daily living (ADLs) (86–89).
However, it was also observed that a 7-years weight gain
pattern among men and women over 65 years old did not
increase the risk of limitation in ADL or mobility compared to
individual who maintained a stable weight (59).
Weight instability and oscillations have been associated with
a higher risk of limitation of ADL and mobility infirmity in the
elderly (59, 79, 90).
Most of the weight changes reported in these studies were
unintentional. In other intervention studies, improvements of
physical performances in obese old adults after intentional
weight loss following dietary restriction were reported. Thus, the
American Society for Nutrition has recognized the functional
benefits of intentional weight loss in obese elderly (91–93);
nevertheless, additional studies are required to set up optimal
weight loss strategies for obese older adults and to assess their
long-term benefits.
Generally, the correlations between BMI and mortality in
the elderly have been described showing U-shaped or J-shaped
relationships. An increased risk of death is associated with a
low BMI (underweight), although a possible causal relationship
linking an underlying illness (for example cancer) causing a
low BMI and the consequent increased mortality rate cannot
be excluded. An increased mortality risk has been sometimes
reported only for obese elderly, while others indicate an increased
mortality risk in overweight old adults. Therefore, a clear
relationship is still a matter of debate (94–96).
Surprisingly, in some observational studies a protective effect
of high levels of body fatness on mortality have been reported
in the elderly (97). However, these studies are potentially
inconsistent due to methodological biases in sampling and
statistical analysis that may increase the reported protective
effects on mortality. In fact, other studies not suffering
from sampling or grouping biases conclude that being either
overweight or obese decrease the chance of a healthy aging. A
J-shaped association between BMI and 10-years mortality was
detected among non-smokers older adults (98). A systematic
review and meta-analysis examining the impact of a high BMI
on mortality risk in older adults concluded that BMI in the
overweight range is not associated with an increased risk of
mortality, whereas obesity showed a significant association with
a higher mortality risk. More recent studies have supported
the finding that a high BMI negatively affects healthy life
expectancy, and it is also associated with an increased risk for
cancer mortality, in particular for colorectal cancer. A difference
between men and women exists in the degree that excess body
weight increases mortality risk (99–106).
Limiting the analysis to very old adults only, obesity appears to
be unrelated to mortality risk and no protective effect of adiposity
was observed (107, 108). It is possible that the relationship
between adiposity and mortality can assume different meanings
depending on the age, and that in some circumstances a higher
BMI may be protective, even though more studies are required
to gain more insights into this relationship. However, most
of the studies conducted so far consider only the BMI as a
measure of adiposity. Since the complexity of body fatness
cannot be completely explained using the sole BMI, some studies
investigated the relationship betweenmortality risk and adiposity
by assessing the impact of different fat compartments. Even these
studies resulted in conflicting evidences (102, 109–112).
Another important predictor of mortality risk in old adults is
represented by body weight change. In particular, a recent study
considering a multiethnic cohort of 63,040 individuals showed
that weight loss rather than gain was associated with an increased
mortality risk (59, 113–118).
As discussed above, these results suggest that unintentional
weight loss may increase mortality risk in older adults, but not
intentional weight loss. Unintentional weight loss may be the
consequence of an underlying disease. Unfortunately, in most of
the studies conducted so far intentional rather than unintentional
weight loss distinction is not very clear. Body weight increase has
not been found to be associated with a higher mortality risk in
older adults (59, 114).
However, using a reliable BC measurement approach,
researchers showed that elderly men who gained >5% fat mass
over a 4.6-years follow-up had a higher mortality risk compared
to men who did not change their fat mass (116). Since weight
gain may be the result of an increase in fat as well as muscle mass,
which can have a different impact on the associated risks, it is
necessary for upcoming studies to evaluate the actual changes
in different body compartments to consider their effects on
mortality risk. A large waist circumference has been associated
with mobility limitations and disabilities in several studies (119–
123). In prospective studies, a high-risk waist circumference at
baseline (of ∼ >102 cm in men and >88 cm in women) was
correlated with a higher incidence of mobility and functional
limitations, with a greater association in inactive older adults (78,
124–130). A longitudinal study assessing a 5.5-years modification
in waist circumference showed that this was not associated
with a change in the self-reported disability, reporting that the
main predictor associated with physical decline was indeed the
reduction in appendicular fat-free mass (74).
Muscle quality and muscle fat infiltration assessed by CT was
associated with a higher risk of incident mobility limitations in
men and women over 70 years old (84, 131–133).
High waist circumference in old adults is also a predictor
of mortality. Increased mortality risk was observed also in
normal BMI individuals who showed a large waist circumference,
even if this association was reported to be dependent on
cardiorespiratory fitness. It is possible that especially in older
men, waist circumference could be a stronger predictor for
mortality risk than BMI itself. In fact, in a study evaluating
the associations between BMI, waist circumference and specific
causes of mortality (such as deaths from lung cancer and chronic
respiratory disease), waist circumference but not BMI showed
statistically significant positive associations with deaths from
major specific causes (102, 110, 134–138). In contrast, it has been
shown a protective effect of a larger waist circumference in adults
of 65 years old (100, 108).
Some studies suggest a negative impact of abdominal fat in life
expectancy of old adults. A J-shaped relationship between DXA-
assessed central adiposity and mortality was described (112).
Similarly, visceral adiposity determined by CT was shown to be
Frontiers in Endocrinology | www.frontiersin.org 9 January 2020 | Volume 10 | Article 861
Ponti et al. Imaging, Aging, and Body Composition
correlated with an increased risk in men over 50 years old (111,
139). A recent analysis investigating the relationship between
BC and inflammation in a large European cohort of elderly has
shown that BC and regional lean/fat distribution can define BC
clusters that differently associate with inflammatory markers and
inflammatory profiles (29).
ASSOCIATIONS OF LEAN MASS WITH
MOBILITY, DISABILITY, AND MORTALITY
It has been suggested that skeletal muscle mass reduction, or
sarcopenia, that occurs in aging is associated with a decline in
functional status in the elderly (70). Indeed, several studies have
shown that sarcopenia is related to a poorer functional status
or to a 5-years functional decline in old age. Surprisingly, two
studies have shown that muscle mass gain rather than loss may
lead to a worse functional status or greater functional decay.
However, this may be due to the interfering role of excess
adiposity, which is associated with a higher skeletal muscle mass
but a poor functional status, thus the importance of considering
the role of body fatness when investigating the correlations
between skeletal muscle mass and functional status changes in
the elderly (139–144). Several studies have shown that sarcopenia
is not associated with or only weakly associated with: (A) a
compromised functional capacity (145–149) and (B) a future
functional decline (84, 85). According to these studies, which
performed careful adjustments for both body fat and body
height, the high body fat mass strongly affects functioning in old
men and women, regardless of the physical activity level of the
participants. This suggests that the impact of an excess body fat
on the functional status in old age is far more important than
a low skeletal muscle mass. In 2004, the concept of sarcopenic
obesity (defined as having a body fat percentage >40% and a
skeletal muscle index <5.45 kg/m2) was launched, following the
results of a study that showed a twofold higher risk of developing
instrumental ADL disability in old sarcopenic adults (based on
a threshold amount for the appendicular skeletal muscle mass
divided by the body height squared) who had a high proportion
of body fat compared to elderly with normal fat levels and
without sarcopenia. However, more recent cross-sectional studies
have not supported the finding that a mixture of low muscle
mass and high body fat mass is more disadvantageous to the
functional status than a high body fat mass alone. Considering
sarcopenia alone, no association with an increased risk of a
poor functional status was observed. One other recent study
conducted on French women showed that compared to obese
women, the sarcopenic obese women tended to have a higher
risk of difficulty descending stairs but no differences were found
for the other six physical function elements investigated in the
study (148, 150–153). According to the present literature, is
not possible to convey that the combination of obesity and
sarcopenia is more damaging for physical performance than
obesity alone. Additionally, it remains unclear whether the risks
associated with sarcopenic obesity are higher than the sum of the
FIGURE 4 | Graphical summary of the standards for DXA, CT, MRI and US for the detection of metabolic dysfunction in elderly. Standards for sarcopenia, obesity and
sarcopenic obesity are summarized.
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single risks of obesity and sarcopenia together. The evaluation of
body masses by the imaging methods described in this review
could support clinical practice for the diagnosis of metabolic
dysfunctions in elderly. In particular, because DXA scan can
evaluate total and regional fat, lean and bone masses with
accuracy for the visceral adiposity in the android compartment,
it represents the gold standard for the diagnosis of sarcopenia,
osteoporosis as well as of the CMR in both obesity and
sarcopenic obesity. MRI, CT, and US are mainly used in research
settings. MRI and CT are gold standards for the evaluation of
inter/intramuscular fat and visceral-perivisceral compartments
particularly important in sarcopenic obesity diagnosis. US is
mainly used to measure subcutaneous, peritoneal and visceral
fat thus being of particular use for the diagnosis of CMR risk in
obesity. The graphical summary reported in Figure 4 shows the
standards for each technique.
A clear association between low muscle mass and functional
decline in elderly has not been assessed due to the lack
of evidences, although it has been suggested that a marked
skeletal muscle mass waste in old age might intensify the
chance of functional limitations and disability. As an example,
a study involving 159 elderly (both males and females) who
were monitored up for 5.5 years, showed that the loss of the
appendicular muscle mass and leg muscle mass (as measured
by DXA) was correlated with a decline of the disability score
(74). Changes in the appendicular skeletal muscle mass over
5 years had a faint and positive association with changes in
physical functioning measures (144). Unfortunately, it remains
not clear whether the actual shrinkage in skeletal muscle mass
or the involuntary decrease of body weight, which in turn leads
to a decrease in skeletal muscle mass, could be the crucial factor
inducing the functional status decline occurring with age. A
recent trial showed that after voluntary weight loss, the loss of
fat mass in the abdomen and thighs compared to the changes
in skeletal muscle mass was the main determinant of improved
functional performance (154, 155).
Only three prospective studies conducted so far evaluated
skeletal muscle mass in an accurate and precise way and
investigated the association between sarcopenia and mortality in
older adults. The Health, Aging and Body Composition Study
showed that the lowmuscle mass in the inferior limbs (as assessed
by CT or DXA) was not strongly associated with a 4.9-years
mortality risk in males and females aged 70–79 years (156).
While in men, the low midthigh muscle cross-sectional region
(as measured by CT) was associated with mortality (HR, 1.26;
95% CI, 1.02–1.55), in women this relationship was not observed
(HR, 0.94; 95% CI, 0.61–1.35). In a cohort of 934 old adults over
65 years old from the In Chianti study it was discovered that the
calf muscle area (as measured by peripheral quantitative CT) was
not associated with a 6-years mortality (111).
In addition, also sarcopenic obesity was not associated
with an increased mortality risk. Lastly, data from 3,153 65+
FIGURE 5 | The changes that usually occur with age such as overall increase of body fat and ectopic fat infiltration and the decrease of skeletal muscle should be
accurately measured in order to add this information to a personalized preventive strategy to counteract age-related disease and disabilities. Although anthropometric
measures, underwater weighting and electric bioimpedance represent cheap, easy and completely safe methods, they do not guarantee a high precision and accuracy
to define BC compartments with none or a scarce definition. On the other hand, imaging techniques can guarantee a very high definition of body compartments either
in fat or lean mass with a high accuracy and precision. However, all the imaging methods expose the subjects to low or medium levels of radiation, are not easily
available and are quite expensive. Depending on the information sought, all these aspects should be taken into account when selecting the method to measure BC.
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Chinese adults, showed similarities between sarcopenic and
non-sarcopenic subjects in terms of 5-years mortality risk
(144). On the whole, these studies systematically show that a
higher mortality risk is not associated with a low muscle mass.
Conversely, a recent study conducted during a 4.6-years follow-
up found that the loss of appendicular muscle mass (as measured
by DXA) was associated with an increased mortality risk in 4,331
males aged 65–93 years (116).
According to the available literature evidence, it is not possible
to rule out the possibility that the increased mortality is actually
caused by the weight loss experienced and the underlying cause of
this loss, considering that in old adults the loss of skeletal muscle
mass is strictly correlated with weight loss (154).
CONCLUSIONS
The changes in BC occurring during lifetime are strictly
related to health status. The increase of fat mass and
the decrease of lean mass typical of elderly have indeed
been associated with the increase of age-related pathologies
and functional decline. A reduced mobility, the onset of
disabilities and falls are among the major cause of reduced
quality of life among elderly. Moreover, the specific increase
of visceral fat in abdomen and of the ectopic fat storage
in other organs and tissues and the decrease of skeletal
muscle mass have been associated with an increased pro-
inflammatory status and insulin resistance that can further
increase the risk of pathologies including CVD and T2D. For
these reasons, the study of composition and distribution of
body masses it is becoming urgent because the inclusion of
information regarding quantity and quality of fat, lean, and
bone tissues could personalize preventive strategies for age-
related pathologies.
Anthropometric measures such as BMI, waist circumference,
waist to hip ratio, underwater weighing and more recently
bioelectrical impedance are widely used to measure BC because
of easy application, low costs and avoid radiation exposure.
However, the precision and accuracy of these methods
is rather low and the level of distinction among different
components of body mass and compartments is poor.
To date, the use of imaging techniques such as US, CT, MRI
and DXA in clinical, but also in research is increasing due to
an elevated precision and accuracy associated with a satisfactory
level of discrimination among body masses.
However, depending on the information requested, specific
advantages and limitations could be envisaged (Figure 5):
i) MRI and CT are imaging modalities that provide
very precise and accurate information for whole body,
inter/intramuscular and visceral fat and for whole body and
regional muscle but they both require a clinical setting, thus
their availability is low, they are quite expensive and the
exposure to radiation is high, in particular for CT;
ii) DXA provides images of whole-body fat and regional muscle
with high precision and accuracy as well as MRI and CT.
It is the most widely used technique for the study of bone
composition and even if it requires a clinical setting it is
relatively available and cheap, while involving a very low
exposure to radiation;
iii) US is mainly used to measure abdominal adiposity. It is a low
cost technique and avoids exposure to radiation, however its
accuracy and reliability is still debated.
Collectively, imaging techniques are very promising in the study
of BC and age-related changes. However, further efforts are
needed to decrease the costs and thus increase the availability
to population.
Lastly, the creation of standardized reference normative
databases should be encouraged among researchers and to this
aim a valid method for the cross-calibration among different
scanners should be established to compare results among
different research centers.
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